BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27080148)

  • 1. Characterization of antibody-drug conjugates by mass spectrometry: advances and future trends.
    Huang RY; Chen G
    Drug Discov Today; 2016 May; 21(5):850-5. PubMed ID: 27080148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the construction of antibody-drug conjugates.
    Chudasama V; Maruani A; Caddick S
    Nat Chem; 2016 Feb; 8(2):114-9. PubMed ID: 26791893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioanalysis in the development of antibody-drug conjugates].
    Li XL; Chen XY; Zhong DF
    Yao Xue Xue Bao; 2016 Apr; 51(4):517-28. PubMed ID: 29859519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical methods for physicochemical characterization of antibody drug conjugates.
    Wakankar A; Chen Y; Gokarn Y; Jacobson FS
    MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Positional Isomers of Interchain Cysteine Linked Antibody-Drug Conjugates by High-Resolution Mass Spectrometry.
    Li K; Lin ZJ; Shi H; Ma Y
    Anal Chem; 2019 Jul; 91(13):8558-8563. PubMed ID: 31247726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.
    Xu K; Liu L; Saad OM; Baudys J; Williams L; Leipold D; Shen B; Raab H; Junutula JR; Kim A; Kaur S
    Anal Biochem; 2011 May; 412(1):56-66. PubMed ID: 21216214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
    Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
    J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar.
    Zhu Z; Ramakrishnan B; Li J; Wang Y; Feng Y; Prabakaran P; Colantonio S; Dyba MA; Qasba PK; Dimitrov DS
    MAbs; 2014; 6(5):1190-200. PubMed ID: 25517304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
    Harper J; Mao S; Strout P; Kamal A
    Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-Drug Conjugates: Design, Formulation and Physicochemical Stability.
    Singh SK; Luisi DL; Pak RH
    Pharm Res; 2015 Nov; 32(11):3541-71. PubMed ID: 25986175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM.
    Nagy G; Attah IK; Conant CR; Liu W; Garimella SVB; Gunawardena HP; Shaw JB; Smith RD; Ibrahim YM
    Anal Chem; 2020 Apr; 92(7):5004-5012. PubMed ID: 32142606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
    Valliere-Douglass JF; Hengel SM; Pan LY
    Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Drug Conjugate: A Novel Drug Design Approach.
    Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
    Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current ADC Linker Chemistry.
    Jain N; Smith SW; Ghone S; Tomczuk B
    Pharm Res; 2015 Nov; 32(11):3526-40. PubMed ID: 25759187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging mass spectrometry for the precise design of antibody-drug conjugates.
    Fujiwara Y; Furuta M; Manabe S; Koga Y; Yasunaga M; Matsumura Y
    Sci Rep; 2016 Apr; 6():24954. PubMed ID: 27098163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calculated conjugated payload from immunoassay and LC-MS intact protein analysis measurements of antibody-drug conjugate.
    Rago B; Clark T; King L; Zhang J; Tumey LN; Li F; Barletta F; Wei C; Leal M; Hansel S; Han X
    Bioanalysis; 2016 Nov; 8(21):2205-2217. PubMed ID: 27682846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of site-specific antibody-drug conjugates].
    Sun Y; Huang R; Sun BW
    Yao Xue Xue Bao; 2015 Oct; 50(10):1225-31. PubMed ID: 26837166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.